IL17A and myeloid sarcoma: A microarray analysis of brain lesions from MS patients, using samples obtained from early post-mortem autopsies, revealed that IL-17A mRNA levels were more than two-fold higher in the lesions of MS patients compared to a control group without MS (Lock et al. 2002).